MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Telehealth Follow-up for Craniofacial Dystonias Treated with Neurotoxin Injection: Physician Outcomes

    K. Harper, L. Kopaeva, L. Venditti, J. Meystedt, M. Hacker, S. Sharp, P. Charles (Nashville, USA)

    Objective: To evaluate the potential benefits of a post-injection telehealth follow-up visit for people with craniofacial dystonia. Background: Craniofacial dystonias, including blepharospasm and oromandibular dystonia,…
  • 2025 International Congress

    Remission of Tardive Dyskinesia in Patients Receiving Long-Term Valbenazine Treatment

    A. Cutler, L. Bahroo, K. Aldrich, E. Liu, C. Zeng, K. Farahmand (Syracuse, USA)

    Objective: To assess a potential threshold for remission of tardive dyskinesia (TD) during treatment with once-daily valbenazine, a uniquely selective vesicular monoamine transporter 2 inhibitor.…
  • 2025 International Congress

    Valbenazine Improves the Burden and Symptoms of Tardive Dyskinesia: Topline Results from the Phase 4 KINECT-PRO Study

    E. Dunayevich, A. Parameswaran, M. Bron, E. Franey, D. Sparta, C. Zeng, S. Mathias, J. Mcevoy (San Diego, USA)

    Objective: To evaluate the effects of once-daily valbenazine (VBZ) on the impacts of tardive dyskinesia (TD) using multiple patient-reported outcomes (PROs), including the psychometrically validated…
  • 2025 International Congress

    Pleozymes, A Multifunctional Nanozyme for Targeting Metabolic Deficits in Friedreich’s Ataxia

    U. Khan, K. Mouli, A. Liopo, P. Derry, T. Kent (Houston, USA)

    Objective: Mitochondrial dysfunction in Friedreich’s Ataxia (FRDA) results from GAA repeat expansion in the FXN gene, reducing frataxin levels thus disrupting iron-sulfur clusters essential for…
  • 2025 International Congress

    Insights into Myoclonus Dystonia from an Indian movement disorder clinic

    F. Mustafa, A. Mudda, A. Agarwal, A. Srivastava, D. Garg, A. Garg (New Delhi, India)

    Objective: To describe the clinical profile, etiology and treatment profile of myoclonus dystonia patients attending a single movement disorder clinic. Background: Myoclonus-dystonia (MD) is a…
  • 2025 International Congress

    The Dutch Yips Study- part V: The VIdeo Panel (VIP)-Study

    E. van Wensen, B. Nijenhuis, E. van Leeuwen, J. Zwerver, M. de Koning-Tijssen, B. Vande Warrenburg, T. Schermer (Apeldoorn, Netherlands)

    Objective: At least 10 international in Movement Disorders specialised neurologists participate in a research study that aims to better understand the origins and the phenomenology of…
  • 2025 International Congress

    Community Awareness of Parkinson’s Disease as a Driver of Stigma in Kilifi, Kenya

    N. Fothergill-Misbah, S. Unda, V. Nyadimo, M. Bitta (Newcastle upon Tyne, United Kingdom)

    Objective: To gain a holistic understanding of stigma surrounding Parkinson’s disease in Kenya from the perspective of those who are stigmatised, and those who might…
  • 2025 International Congress

    Hemiplegic Migraine Masquerading as Dystonia

    L. Jaffe (Honolulu, USA)

    Objective: To identify the myriad ways migraine can present, including with muscle spasm(s) that can appear to be dystonia and thus serve to make this…
  • 2025 International Congress

    Bodily Maps of Symptoms and Emotions in Dystonia

    K. Niemi, E. Ottela, A. Huovinen, E. Glerean, L. Nummenmaa, E. Jaakkola, J. Joutsa (Turku, Finland)

    Objective: To investigate symptom- and emotion-related sensations in dystonia. Background: Dystonia is a chronic movement disorder characterized by excessive muscle activity leading to involuntary movement…
  • 2025 International Congress

    Understanding Family and Clinician Perspectives on Treatment Decision-Making for Acute Dystonia Exacerbations in Children

    L. Vogt, A. Leblanc-Millar, S. Breitbart, N. Al Azri, A. Fasano, K. Nelson, C. Gorodetsky (Toronto, Canada)

    Objective: Primary: To identify factors influencing the decision to provide acute pharmacological treatment for dystonia exacerbations in hospitalized pediatric patients. Secondary: To assess the alignment…
  • « Previous Page
  • 1
  • …
  • 238
  • 239
  • 240
  • 241
  • 242
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley